Bioventix PLC | Mutual Funds
Mutual Funds that own Bioventix PLC
ConBrio Sanford DeLand UK Buffettology Fund
400,000
7.78%
120,000
6.29%
08/31/2017
CF Miton UK Multi Cap Income Fund
336,367
6.54%
0
1.17%
09/29/2017
Marlborough UK Micro Cap Growth Fund
254,187
4.95%
-10,746
0.7%
03/29/2018
Baronsmead VCT 3 Plc
208,658
4.05%
2,991
3.63%
09/30/2017
Diverse Income Trust Plc (The)
207,177
4.03%
-34,354
1.71%
05/31/2017
Jupiter UK Smaller Companies Fund
200,000
3.89%
30,000
2.13%
02/28/2018
Baronsmead VCT 2 Plc
170,703
3.32%
2,424
3.45%
09/30/2017
Marlborough Multi Cap Income Fund
165,625
3.22%
43,375
0.35%
03/29/2018
Objectif Investissement Micro Caps
142,390
2.77%
0
2.63%
03/29/2018
CF Miton UK Smaller Companies Fund
79,000
1.54%
-16,000
1.3%
09/29/2017
| Address |
7 Romans Business Park
Farnham Surrey GU9 7SX
United Kingdom
|
|
Employees
|
- |
| Website |
http://bioventix.com |
| Updated |
07/08/2019 |
| Bioventix Plc engages in the development and supply of antibodies. It is involved in the development and manufacture of sheep monoclonal antibodies for use in the fields of clinical diagnostics and drugs of abuse testing. The company was founded on October 7, 2003 and is headquartered in Farnham, the United Kingdom. |
